Ginger and Crohn's Disease: IBD, Inflamed Bowel, and Remission

Inflammatory bowel diseases (IBD) — Crohn's disease and ulcerative colitis (UC) — affect more than 1 million Europeans. Ginger, with its specific anti-inflammatory action in the gut, is generating increasing interest as a complementary support.

Mechanisms of Action in IBD

IBD involves abnormal activation of NF-κB in the intestinal mucosa, leading to an overproduction of TNF-α, IL-1β, and IL-6. Ginger precisely inhibits this cascade:

• Inhibition of NF-κB in colonocytes (colon cells)
• Reduction of mucosal TNF-α
• Protection of the intestinal epithelial barrier
• Reduction of intestinal permeability (leaky gut)

Preclinical Studies on Crohn's and UC

Animal models of colitis (TNBS and DSS) show that ginger extract significantly reduces disease activity scores, leukocyte infiltration, and mucosal lesions. Human studies are still limited, but a pilot study (2019) on 24 patients with mild to moderate UC showed an improvement in endoscopic scores after 8 weeks.

FODMAP and IBD: The Choice of Sweetener Matters

Many IBD patients follow a low-FODMAP diet. Erythritol (in INTI Drink) is the best-tolerated polyol — 90% absorbed before the colon, it does not ferment and does not create gas. Cane sugar in INTI vs GIMBER comparison (~34g/100ml) can worsen symptoms in IBD patients sensitive to sucrose.

Ginger as Support during Remission

Ginger can be considered as a complementary support during remission to reduce underlying inflammation and prevent relapses. It does not replace basic treatments (mesalamine, azathioprine, biologics). Consult your gastroenterologist before any use.